Charles River Laboratories has a market cap of $1.63 billion; its shares were traded at around $32.27 with a P/E ratio of 12.5 and P/S ratio of 1.4.
CFO Recent Trades:
- Corp. Executive VP & CFO Thomas F Ackerman sold 11,500 shares of CRL stock on 07/03/2012 at the average price of 34. Thomas F Ackerman owns at least 121,887 shares after this. The price of the stock has decreased by 5.09% since.
- Corp. Executive VP & CFO Thomas F Ackerman sold 200 shares of CRL stock on 06/21/2012 at the average price of 34. Thomas F Ackerman owns at least 122,087 shares after this. The price of the stock has decreased by 5.09% since.
This is the insider trade history vs. stock price of CRL. For the complete insider trading history of CRL, click here.
Directors and Officers Recent Trades:
- Corp Executive VP David P Johst sold 20,290 shares of CRL stock on 07/06/2012 at the average price of 33.5. David P Johst owns at least 138,092 shares after this. The price of the stock has decreased by 3.67% since.
- Director George Massaro sold 1,140 shares of CRL stock on 06/22/2012 at the average price of 32.88. George Massaro owns at least 22,148 shares after this. The price of the stock has decreased by 1.86% since.
- Director Stephen D Chubb sold 1,000 shares of CRL stock on 04/02/2012 at the average price of 36.22. Stephen D Chubb owns at least 29,563 shares after this. The price of the stock has decreased by 10.91% since.
- Director Richard F Wallman sold 5,000 shares of CRL stock on 03/05/2012 at the average price of 35.31. Richard F Wallman owns at least 10,920 shares after this. The price of the stock has decreased by 8.61% since.
- Corporate Executive VP Jorg Geller sold 1,138 shares of CRL stock on 02/29/2012 at the average price of 35.46. Jorg Geller owns at least 53,148 shares after this. The price of the stock has decreased by 9% since.
For the complete insider trading history of CRL, click here.







RSS